Hormone Optimisation & Vitality
Evaluating visceral fat reduction and muscle preservation.
Promoting natural hormone balance and vibrant energy.
Age-induced endocrine shifts frequently trigger internal fatigue and structural muscle loss. This research pathway investigates neuroendocrine support to protect lean mass and restore baseline vitality.
Expected Research Benefits
Endocrine Homeostasis
Supporting mid-life endocrine balance.
Visceral Fat Reduction
Investigating the reduction of deep abdominal fat storage.
Muscle Preservation
Protecting structural contours and metabolic lean mass.
The Evaluation Process
Endocrine Priming: Mid-life neuroendocrine receptors are gently supported, stabilizing energy drops and reducing deep systemic lethargy.
Lean Mass Protection: IGF-1 and growth hormone pathways are optimised, triggering the steady reduction of stubborn visceral abdominal fat.
Homeostatic Balance: Biological contours are reinforced, lean structural mass is preserved, and a vibrant endocrine baseline is re-established.
HORMONE OPTIMISATION & VITALITY PEPTIDE PENS
AOD9604 10MG
For in vitro use onlyThe Mechanism: A modified C-terminal fragment of human growth hormone that specifically stimulates lipolysis (fat breakdown) and inhibits lipogenesis (fat accumulation) without impacting blood sugar. Best For: Targeted visceral abdominal fat reduction and body contouring.
MOTS-C 30MG
For in vitro use onlyThe Mechanism: A mitochondrial-encoded peptide that regulates systemic metabolic homeostasis, protecting lean muscle mass from breakdown and mimicking the metabolic benefits of active exercise. Best For: Preserving lean structural mass and driving cellular metabolic efficiency.
TESAMORELIN 30MG
For in vitro use onlyThe Mechanism: A potent Growth Hormone-Releasing Hormone (GHRH) analogue that stimulates endogenous growth hormone secretion, targeting deep visceral fat reserves and optimizing mid-life vitality markers. Best For: Visceral fat clearance, structural lean mass development, and vitality restoration.